Sign In
Buy NRXP
$4.05
-0.570 (-12.34%)
At Close: Jun 03, 2026
NRXP Stock: Why It Substantially Increased
05:20am, Wednesday, 13'th Oct 2021
The stock price of NRx Pharmaceuticals Inc (NASDAQ: NRXP) increased by over 61% yesterday. This is why it happened.
Why NRX Pharmaceuticals Shares Are Rising
03:54pm, Tuesday, 12'th Oct 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) shares are trading higher by 54.1% at $10.45 after the company announced progress on the worldwide commercial-scale development of ZYESAMI. The company announced
Why NRx Pharmaceuticals Stock Is Skyrocketing Today
03:34pm, Tuesday, 12'th Oct 2021
The company announced progress on two fronts for its experimental COVID-19 drug Zyesami.
RADNOR, Pa., Sept. 29, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (NASDAQ: NRXP), a clinical stage, biopharmaceutical company today provided a safety update on ZYESAMI™ (aviptadil) which is bein
NRx Pharma's COVID-19 Candidate Shows Improved Survival At One Year
09:28am, Monday, 27'th Sep 2021
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced top-line data demonstrating improved outcomes at one year in highly comorbid patients with COVID-19 treated with Zyesami. Between June and Septe
RADNOR, Pa., Sept. 27, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), a clinical stage, biopharmaceutical company, today announced top line data demonstrating improved outcomes at one year
IQVIA (IQV) Announces Collaboration With NRx Pharmaceuticals
12:59pm, Tuesday, 14'th Sep 2021
IQVIA (IQV) and NRx are set to work closely to support activities essential for emergency use authorization of ZYESAMI.
Why Are NRx Pharma Shares Moving Higher On Tuesday Premarket?
08:17am, Tuesday, 14'th Sep 2021
Iqvia Holdings Inc (NYSE: IQV) has collaborated with NRx Pharmaceuticals Inc (NASDAQ: NRXP) to provide pharmacovigilance services and medical information in preparation for potential regulatory a
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
04:15pm, Monday, 13'th Sep 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry,
NRx Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
07:48am, Wednesday, 08'th Sep 2021
RADNOR, Pa., Sept. 8, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) today announced that NRx's management team will present and host one-on-one investor meetings at the upcoming H.C.
NRx Pharma Stock Is Moving Higher On COVID-19 Candidate Data
10:57am, Monday, 30'th Aug 2021
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced an additional finding from its Phase 2b/3 trial investigating Zyesami (aviptadil) for critically ill COVID-19 patients with acute respiratory fa
RADNOR, Pa., Aug. 30, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced an additional finding in its phase 2b/3 clinical trial investigating ZYESAMI™ (aviptadil) for the treat
NRx Pharma, Cardinal Health Ink Zyesami Distribution Pact
12:50pm, Thursday, 26'th Aug 2021
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has signed an agreement with Cardinal Health Inc (NYSE: CAH) to provide third-party logistics and distribution of Zyesami upon the potential FDA Emergency Use Au
NRXP Stock: Over 16% Increase Explanation
12:28pm, Thursday, 26'th Aug 2021
The stock price of NRx Pharmaceuticals (Nasdaq: NRXP) increased by over 16% during intraday trading. This is why it happened.
NRx Pharmaceuticals to Work with Cardinal Health to Ensure Efficient Distribution of Potential Therapies
06:48am, Thursday, 26'th Aug 2021
RADNOR, Pa., Aug. 26, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today it has signed an agreement with Cardinal Health to provide third party logistics and distribution of
